Combined analysis of clinical and laboratory markers to predict the risk of venous thromboembolism in patients with IDH1 wild-type glioblastoma.
Yong HuangHaixia DingMin LuoSirui LiConghua XieYa-Hua ZhongZhiqiang LiPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)
In IDH1wt GBM patients, by applying a VTE risk assessment model, we could identify patients with a very high and low risk of VTE.